CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 30 enrolled
Drug / intervention
Brain Octane Oil +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04095728
NCT04095728N/ACompleted

A Randomized, Double-blind, Placebo-controlled, Parallel Study Investigating the Efficacy of Brain Octane® Oil (Caprylic Acid Triglycerides) on Cognition, Coordination, Reaction Time and Measurements of Physical Performance in Recreationally Active Adults

Bulletproof 360, Inc.·interventional·Posted Sep 19, 2019·Updated Jan 27, 2021

In Brief

A clinical study evaluating Brain Octane Oil and Placebo for Healthy. Completed, enrolled 30 participants across 1 site.

Detailed Summary

This is a randomized, double-blind, placebo-controlled, parallel study investigating the efficacy of Brain Octane® Oil on cognition, coordination, reaction time and measurements of physical performance in recreationally active adults. Thirty eligible participants will consume the investigational product or placebo for 27 days. 15 participants will consume the investigational product and 15 participants will receive the placebo product to consume. The primary outcome is assessing reaction time, cognition, and the ability to perform cognitive tasks. Assessments will be conducted at baseline, and end of study (30 days apart).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesCanada
CollaboratorsKGK Science Inc.

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedSep 19, 2019
Enrollment StartSep 30, 2019
Primary CompletionFeb 29, 2020
Study CompletionMay 29, 2020
TodayJul 1, 2026
Enrollment to primary: 5 monthsPosted 6.8 years ago

Interventions

Brain Octane Oildietary

Participants will complete a 7-day dose escalation period, and then consume 2 servings of the study product (1 serving = 1 tablespoon) for 21 days.

Placeboother

Participants will complete a 7-day dose escalation period, and then consume 2 servings of the study product (1 serving = 1 tablespoon) for 21 days.